Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging drugs for the treatment of anxiety
James W. Murrough, Sahab Yaqubi, Sehrish Sayed, et al.
Expert Opinion on Emerging Drugs (2015) Vol. 20, Iss. 3, pp. 393-406
Open Access | Times Cited: 153

Showing 1-25 of 153 citing articles:

Anxiety disorders
Michelle G. Craske, Murray B. Stein, Thalia C. Eley, et al.
Nature Reviews Disease Primers (2017) Vol. 3, Iss. 1
Open Access | Times Cited: 424
Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders
Simone B. Sartori, Nicolas Singewald
Pharmacology & Therapeutics (2019) Vol. 204, pp. 107402-107402
Open Access | Times Cited: 205
The Pharmacological Action of Kaempferol in Central Nervous System Diseases: A Review
Jéssica Silva dos Santos, João Pedro Gonçalves Cirino, Patrícia de Oliveira Carvalho, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 194
Essential Oils: Pharmaceutical Applications and Encapsulation Strategies into Lipid-Based Delivery Systems
Cinzia Cimino, Oriana Maria Maurel, Teresa Musumeci, et al.
Pharmaceutics (2021) Vol. 13, Iss. 3, pp. 327-327
Open Access | Times Cited: 193
A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)
Jiangling Peng, Mingjie Fan, Chelsea An, et al.
Basic & Clinical Pharmacology & Toxicology (2022) Vol. 130, Iss. 4, pp. 439-456
Open Access | Times Cited: 177
GWAS of peptic ulcer disease implicates Helicobacter pylori infection, other gastrointestinal disorders and depression
Yeda Wu, Graham K. Murray, Enda M. Byrne, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 162
Gut Microbiota in Anxiety and Depression: Unveiling the Relationships and Management Options
Akash Kumar, Jhilam Pramanik, Nandani Goyal, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 565-565
Open Access | Times Cited: 43
Use of cannabidiol in anxiety and anxiety-related disorders
Jessica W. Skelley, Crystal M. Deas, Zachary Curren, et al.
Journal of the American Pharmacists Association (2019) Vol. 60, Iss. 1, pp. 253-261
Closed Access | Times Cited: 116
The P2X7 Receptor: Central Hub of Brain Diseases
Roberta Andrejew, Ágatha Oliveira‐Giacomelli, Deidiane Elisa Ribeiro, et al.
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 115
Cannabinoid Regulation of Fear and Anxiety: an Update
Eleni P. Papagianni, Carl W. Stevenson
Current Psychiatry Reports (2019) Vol. 21, Iss. 6
Open Access | Times Cited: 94
The imidazodiazepine, KRM-II-81: An example of a newly emerging generation of GABAkines for neurological and psychiatric disorders
Jeffrey M. Witkin, Arnold S. Lippa, Jodi L. Smith, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 213, pp. 173321-173321
Closed Access | Times Cited: 39
Hippocampus: Molecular, Cellular, and Circuit Features in Anxiety
Hu‐Jiang Shi, Shuang Wang, Xinping Wang, et al.
Neuroscience Bulletin (2023) Vol. 39, Iss. 6, pp. 1009-1026
Open Access | Times Cited: 37
Glutamate Systems in DSM-5 Anxiety Disorders: Their Role and a Review of Glutamate and GABA Psychopharmacology
Madeeha Nasir, Daniel Trujillo, Jessica L.S. Levine, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 62
Use of Cannabidiol for the Treatment of Anxiety: A Short Synthesis of Pre-Clinical and Clinical Evidence
Madison Wright, Patricia Di Ciano, Bruna Brands
Cannabis and Cannabinoid Research (2020) Vol. 5, Iss. 3, pp. 191-196
Open Access | Times Cited: 61
Assessment of behavioral changes and antitumor effects of silver nanoparticles synthesized using diosgenin in mice model
Uma Maheshwari Rajadurai, Abirami Hariharan, Durairaj Siva, et al.
Journal of Drug Delivery Science and Technology (2021) Vol. 66, pp. 102766-102766
Closed Access | Times Cited: 44
Relationship between human oral microbiome dysbiosis and neuropsychiatric diseases: An updated overview
Kai Tao, Yanling Yuan, Qinglian Xie, et al.
Behavioural Brain Research (2024) Vol. 471, pp. 115111-115111
Closed Access | Times Cited: 6
Treatment-resistant panic disorder: clinical significance, concept and management
Mu‐Hong Chen, Shih‐Jen Tsai
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2016) Vol. 70, pp. 219-226
Closed Access | Times Cited: 56
Higher- and lower-order personality traits and cluster subtypes in social anxiety disorder
Mădălina Elena Costache, Andreas Frick, Kristoffer Månsson, et al.
PLoS ONE (2020) Vol. 15, Iss. 4, pp. e0232187-e0232187
Open Access | Times Cited: 42
Flavonoids for depression and anxiety: a systematic review and meta-analysis
Siqi Jia, Yali Hou, Dan Wang, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 27, pp. 8839-8849
Closed Access | Times Cited: 26
Neuropharmacology of Organoselenium Compounds in Mental Disorders and Degenerative Diseases
Paloma T. Birmann, Angela Maria Casaril, Laura Abenante, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 21, pp. 2357-2395
Closed Access | Times Cited: 23
Recent developments in intranasal drug delivery of nanomedicines for the treatment of neuropsychiatric disorders
Anglina Kisku, Ambresh Nishad, Saurabh Agrawal, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 5
The Microbial and Metabolic Link Between Gut and Brain
Rand Salamalek, Yasmin Shareef, Farah Abdulridha, et al.
(2025), pp. 441-469
Closed Access
Analysis of Anxiety Disorders and Post-Traumatic Stress Disorders for Screening Anxiolytic Drugs and Linking Preclinical and Clinical Research
Anna Kozłowska, Wan-Jiun Ma, Bai‐Chuang Shyu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1414-1414
Open Access
The light-dark forced swim test for simultaneous assessment of behavioral ‘despair’ and anxiety-like behavior in female mice
Sergey L. Khatsko, Alexander V. Zhdanov, Daria V Kravchenko, et al.
Behavioural Brain Research (2025) Vol. 484, pp. 115492-115492
Closed Access
Human pharmacology of positive GABA-A subtype-selective receptor modulators for the treatment of anxiety
Xia Chen, Joop van Gerven, Adam F. Cohen, et al.
Acta Pharmacologica Sinica (2018) Vol. 40, Iss. 5, pp. 571-582
Open Access | Times Cited: 42
Page 1 - Next Page

Scroll to top